Clinical Trial Update: BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

The BRE-08 Phase II trial evaluating the CMC Regimen for early-stage breast cancer is currently recruiting, sponsored by the University of Illinois at Chicago.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CMC Regimen

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING